INT174297

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.51
First Reported 2003
Last Reported 2010
Negated 0
Speculated 1
Reported most in Body
Documents 6
Total Number 7
Disease Relevance 3.26
Pain Relevance 0.42

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

Anatomy Link Frequency
dentine 1
incisors 1
MOS (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 21 97.36 Very High Very High Very High
cytokine 4 87.60 High High
Inflammation 8 87.20 High High
tolerance 6 77.20 Quite High
agonist 9 67.68 Quite High
cva 3 47.52 Quite Low
corticosteroid 3 35.12 Quite Low
abdominal pain 3 14.76 Low Low
headache 3 13.60 Low Low
Neuritis 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Mycobacterium Infection 118 100.00 Very High Very High Very High
Sarcoma 53 100.00 Very High Very High Very High
Chronic Disease 1 98.60 Very High Very High Very High
Mental Disorders 2 98.12 Very High Very High Very High
Pain 20 97.36 Very High Very High Very High
Granuloma 2 91.56 High High
INFLAMMATION 8 87.20 High High
Osteoporosis 2 84.52 Quite High
Fatigue 3 83.52 Quite High
Cancer 53 81.04 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
The present study was designed to assess the effectiveness of the s.c. administration of Merional®, a new highly-purified form of hMG, in inducing MOS in IVF patients, and to compare it with the same drug given i.m at comparable doses.
Positive_regulation (inducing) of MOS
1) Confidence 0.51 Published 2007 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2216030 Disease Relevance 0.06 Pain Relevance 0.04
the MOS and was used for the screening of patients for chronic disease
Positive_regulation (used) of MOS associated with chronic disease
2) Confidence 0.43 Published 2003 Journal Health Qual Life Outcomes Section Body Doc Link PMC183842 Disease Relevance 0.81 Pain Relevance 0.18
Patients were randomised using a computer-assisted 1:1 randomization to undergo MOS with either Merional® administered subcutaneously (s.c.) or by intramuscular (i.m.) injections.
Positive_regulation (undergo) of MOS
3) Confidence 0.34 Published 2007 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2216030 Disease Relevance 0.22 Pain Relevance 0.03
This prospective, controlled, randomised, parallel group open label, multicenter, phase III, equivalence study has been aimed to compare the clinical effectiveness, tolerability (both local and systemic) and safety of Merional® s.c. administration versus i.m. injection in normogonadotrophic patients undergoing MOS in an IVF program.


Positive_regulation (undergoing) of MOS
4) Confidence 0.34 Published 2007 Journal Reprod Biol Endocrinol Section Body Doc Link PMC2216030 Disease Relevance 0 Pain Relevance 0
The aim of this policy was to reduce misdiagnosis and re-registration and to increase the leprosy diagnostic skills of PHC MOs.
Positive_regulation (increase) of MOs associated with mycobacterium infection
5) Confidence 0.23 Published 2009 Journal PLoS ONE Section Body Doc Link PMC2791232 Disease Relevance 0.96 Pain Relevance 0
The aim of this study is to examine the timing of MSV sarcoma induction on locally induced bone by demineralized murine lower incisors.
Spec (examine) Positive_regulation (induction) of MSV in incisors associated with sarcoma
6) Confidence 0.04 Published 2010 Journal International Journal of Molecular Sciences Section Body Doc Link PMC2956094 Disease Relevance 0.61 Pain Relevance 0.09
In this study, MSV-sarcomas were induced during the early, preosteogenic stage of bone induction (virus injection 4 days post dentine implantation) or at a late stage, when chondro- and osteogenesis is advanced (virus injection 12 days post dentine implantation).
Positive_regulation (induced) of MSV in dentine associated with sarcoma
7) Confidence 0.04 Published 2010 Journal International Journal of Molecular Sciences Section Body Doc Link PMC2956094 Disease Relevance 0.61 Pain Relevance 0.08

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox